tiprankstipranks
Trending News
More News >

Neuroscientific Biopharmaceuticals Ltd to Quote New Securities on ASX

Story Highlights
Neuroscientific Biopharmaceuticals Ltd to Quote New Securities on ASX

Don’t Miss TipRanks’ Half-Year Sale

Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) has issued an announcement.

Neuroscientific Biopharmaceuticals Ltd announced the application for the quotation of 85,714,264 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting stakeholders by increasing the accessibility of its shares.

More about Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd is a company operating in the biopharmaceutical industry, focusing on the development of neurological therapies. The company is engaged in creating innovative treatments for neurodegenerative conditions.

Average Trading Volume: 428,090

Technical Sentiment Signal: Buy

Current Market Cap: A$13.01M

For an in-depth examination of NSB stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1